Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

被引:0
|
作者
Zhao-Xia Yang
Wei Shen
Hang Sun
机构
[1] The Second Affiliated Hospital Chongqing Medical University,Department of Gastroenterology and Hepatology
[2] Institute for Viral Hepatitis of Chongqing Medical University,undefined
[3] Chongqing Medical University,undefined
来源
Hepatology International | 2010年 / 4卷
关键词
FXR; Human; NAFLD; Lipid metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:741 / 748
页数:7
相关论文
共 50 条
  • [21] Orthotopic Liver Transplantation in Non-Alcoholic Fatty Liver Disease Patients
    Burra, Patrizia
    Germani, Giacomo
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 210 - 216
  • [22] White tea alleviates non-alcoholic fatty liver disease by regulating energy expenditure and lipid metabolism
    Li, Na
    Zhou, Xingquan
    Wang, Jiuchen
    Chen, Jiayuan
    Lu, Yi
    Sun, Yongzhan
    Song, Yandong
    Tan, Xiaoli
    Xie, Guangchao
    Chen, Yupeng
    Zhang, Lirong
    GENE, 2022, 833
  • [23] Non-alcoholic fatty liver disease and liver secretome
    Khan, Muhammad Sohaib
    Lee, Choongho
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963
  • [24] Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
    Li, Yuan
    Adeniji, Nia T.
    Fan, Weiguo
    Kunimoto, Koshi
    Torok, Natalie J.
    AGING AND DISEASE, 2022, 13 (04): : 1239 - 1251
  • [25] Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease
    Liu, Yuanbin
    Chen, Mingkai
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2023, 24 (06) : 465 - 476
  • [26] Targeting regulation of lipid metabolism with polysaccharide of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease: A review
    Liu, Wei
    Sun, Meng
    Zhang, Hao
    Wang, Wen-Ting
    Song, Jian
    Wang, Meng-Yang
    Wang, Chun-Mei
    Sun, Hai-Ming
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306
  • [27] Phospholipid metabolism in the liver-Implications for phosphatidylserine in non-alcoholic fatty liver disease
    Anari, Marziyeh
    Montgomery, Magdalene K.
    BIOCHEMICAL PHARMACOLOGY, 2023, 213
  • [28] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [29] Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease
    Xu, Jiao-Ya
    Li, Zhong-Ping
    Zhang, Li
    Ji, Guang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (37) : 13493 - 13500
  • [30] Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease
    Ikegami, Tadashi
    Hyogo, Hideyuki
    Honda, Akira
    Miyazaki, Teruo
    Tokushige, Katsutoshi
    Hashimoto, Etsuko
    Inui, Kazuo
    Matsuzaki, Yasushi
    Tazuma, Susumu
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (11) : 1257 - 1266